Gaithersburg's Emergent BioSolutions supports HHS' Anthrax Preparedness Strategy with plans to deliver up to $1B in BioThrax to the Strategic Nat'l Stockpile.
Baltimore's Paragon Biosciences receives a Multiple Award IDIQ Contract from NIAID vvalued up to $159M for preclinical drug development services.
Lutherville's Agrimetus raises $23.5M in Series B funds to further the discovery, development and delivery of new innovative agriculture crop protection products.
Gaithersburg's Altimmune and Pharmathene announce merger to create immunotherapeutics company targeting infectious diseases.
Rockville's Synthetic Biologics confirms key features of pivotal Phase 2b/3 Trial of SYN-010 for IBS-C, and also shares positive results in Phase 2b Trial for C. diff.
Baltimore's Profectus BioSciences' bivalent VesiculoVax™ vaccine protects animals from infection and death after exposure to Chikungunya or the Zika virus.
Bethesda's BrainScope launches its Ahead 300 device for objective Point of Care assessment of mild head injury, including concussion.
Rockville's GlycoMimetics GMI-1271 yields high remission rates, favorable tolerability in two Phase 2 arms of ongoing Phase 1/2 Clinical Trial for AML.
Baltimore's Glyscend, type 2 diabetes startup, wins $500K from in J&J.
Columbia's Well Doc announces FDA clearance of the wireless integration of its diabetes management platform into J&J's latest blood glucose monitor.
Baltimore's Personal Genome Diagnostics™ genomic analyses technology demonstrates how resistance to checkpoint blockade therapy evolves in Cancer.
Rockville's Promaxo and Baltimore's Sage Pharma each receive $200,000 from TEDCO's Life Science Investment Fund for technologies requiring FDA approval.
Gaithersburg's MaxCyte's technology used NIH NIAID study demonstrating CRISPR-Cas9 repair of X-linked Chronic Granulomatous Disease (CGD).
Rockville's RegeneRx receives notice of a cceptance for patent in Australia and intent to grant patent in EU for treatment of neural injury with Thymosin Beta 4.
Columbia's Osiris Therapeutics demonstrates antimicrobial properties of human cryopreserved viable amniotic membrane in treatment of chronic wounds.
Baltimore's UnderArmour partners with Johns Hopkins Medicine to collaborate on fitness product innovation based on science.
Rockville's IDT-Biologika establishes animal health americas business unit.
Germantown's Qiagen enhances bioinformatics portfolio with OmniSoft acquisition.
Columbia's A-Cell now is exclusive US distributor for Southmedic's DTS products.
Gaithersburg's Opgen collaborates with Merck to develop novel rapid diagnostics and informatics tools to combat antibiotic resistance.
Rockville's Sanaria announces that its PfSPZ vaccine provides high-level defense against Malaria in U.S. Navy and Army clinical investigation.
Annapolis' Vixiar Medical moves forward with commercialization of its first product, a non-invasive, handheld POC device for monitoring worsening heart failure.
Rockville's KeyGene USA collaborates with Phenome Networks on crop innovation technologies and continues genomic big data solutions partnership with GENALICE.
Bethesda's Get Well Network's all-in-one patient life console (PLC) used in VA Medical Centers achieves silver level EPEAT certification.
University of Maryland key partner in NIST grant with 150 organizations focused on bringing safe biopharma products to market faster and on workforce training.
|
|
Upcoming Deadlines and Events
|
ACell (Columbia)
To view more job opportunities, Emmes (Rockville) please check at the bottom of the MD COMMERCE
GSK (Rockville) BioHealth and Life Sciences web page.
Paragon Bioservices(Baltimore)
Personal Genome Diagnostics (Baltimore) |
|
Gain Visibility for Your Firm at BIO 2017 in San Diego
|
(Spots only $5-$8.5K)
and/or
|
|
The Maryland Department of Commerce focuses on attracting, retaining, and expanding businesses and creating jobs in Maryland, and also markets Maryland's many assets to companies across the nation and abroad.
The Department's Office of BioHealth and Life Sciences supports innovative start-ups and companies focused on animal and human health, health IT, research tools, and related technologies. These include those involving agricultural and marine bio, biodefense, therapeutics, vaccines, diagnostics, medical devices, biologics, nutraceuticals, personalized and regenerative medicine, digital health, mHealth, telemedicine, EHR, bioinformatics, data center services, patient engagement, and wellness.
|
|
|
|
